Lea Booker
Acute Care · Houston, TXNPI 1982805743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,032 of the $5,298 with a category attached, or 76.1%. Abbott accounts for 62.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $2,038 and has fallen 81.9% since, to $370 in 2025. Among acute care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $56.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Impulse Dynamics (USA) Inc.$880
- Novartis$281
- Abiomed$150
- Boehringer Ingelheim$142
- Merck$117
- plus $395 from 12 others
What the payments were for
- Travel & lodging$1,25224%
- Food & beverage$4,03276%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 42 | $3,334 |
| Impulse Dynamics (USA) Inc. | 10 | $880 |
| Novartis | 11 | $281 |
| Abiomed | 1 | $150 |
| Boehringer Ingelheim | 3 | $142 |
| Merck | 8 | $117 |
| Amgen | 5 | $114 |
| Atricure, Inc. | 1 | $56 |
| Bayer | 2 | $46 |
| Vifor Pharma, Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $22 |
| Pfizer | 1 | $21 |
| Ancora Heart, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,298 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $86 |
| Spironolactone | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other acute care in Houston
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Michelle JohnstonHouston$18K
- Amanda BergeronHouston$12K
- Nicole OnaHouston$12K
- Prashanth AnumandlaHouston$12K
- Ken ChanHouston$11K
- Brittney RichardHouston$11K
- Antonio Paolo AlmacenHouston$11K
- Laura WuesteHouston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.